Therapy for Children With Advanced Stage Neuroblastoma
Public ClinicalTrials.gov record NCT01857934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Neuroblastoma Protocol 2012: Therapy for Children With Advanced Stage High-Risk Neuroblastoma
Study identification
- NCT ID
- NCT01857934
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Enrollment
- 153 participants
Conditions and interventions
Conditions
Interventions
- CliniMACS Device
- G-CSF Biological
- GM-CSF Biological
- Isotretinoin Drug
- busulfan Drug
- cisplatin Drug
- cyclophosphamide Drug
- doxorubicin Drug
- etoposide Drug
- hu14.18K322A Biological
- interleukin-2 Biological
- levetiracetam Drug
- melphalan Drug
- mesna Drug
- natural killer cell infusion Biological
- peripheral blood stem cell harvest Procedure
- peripheral blood stem cell transplantation Biological
- radiation therapy Radiation
- surgical resection Procedure
- topotecan Drug
- vincristine Drug
Device · Biological · Drug + 2 more
Eligibility (public fields only)
- Age range
- Up to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 4, 2013
- Primary completion
- Oct 20, 2021
- Completion
- Dec 30, 2025
- Last update posted
- Apr 15, 2026
2013 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01857934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2026 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01857934 live on ClinicalTrials.gov.